In-Depth: La Jolla Institute takes comprehensive look at COVID-19 immunity
Study compares four vaccines and natural immunity
LJI and Synbal, Inc. partner to develop better COVID-19 models
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
A COVID-fighter’s guide to T cells
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
La Jolla Institute for Immunology opens Center for Clinical Investigation
LA JOLLA – Today, La Jolla Institute for Immunology (LJI) celebrated the opening of the John and Susan Major
The new CEO of the La Jolla Institute for Immunology ascended by lifting others
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
A new window into autoimmune diseases
LJI scientists uncover coordinated immune cell activity as a driver of systemic lupus erythematosus
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Amnon Altman: Leading immunologist and educator retires
Dr. Altman’s research into T cell activation opened the door to new therapies for inflammation, autoimmune diseases, cancers, and more.
Unmasking the pancreas
No one knows exactly what triggers type 1 diabetes, but researchers at La Jolla Institute for Immunology have uncovered some fascinating clues.
Tempus dare: A time to give
San Diego biotech entrepreneurs François Ferré, Ph.D., and Magda Marquet, Ph.D., knew supporting LJI would be critical for advancing our understanding of COVID-19.
Q&A with Bjoern Peters, Ph.D.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.